Evidence map›Paper›PMID 37834347›Full record

ArticleInternational journal of molecular sciences2023

New Benzamides as Multi-Targeted Compounds: A Study on Synthesis, AChE and BACE1 Inhibitory Activity and Molecular Docking.

Danuta Drozdowska, Dawid Maliszewski, Agnieszka Wróbel, Artur Ratkiewicz, Michał Sienkiewicz

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Structural Bioinformatics Applied to Acetylcholinesterase Enzyme Inhibition.International journal of molecular sciences · 2025
    Review
  7. Special Issue "Advances in Drug Discovery and Synthesis".International journal of molecular sciences · 2025
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Danuta DrozdowskaDepartment of Organic Chemistry, Medical University of Białystok, Mickiewicza Street 2A, 15-222 Białystok, Poland.ORCID 0000-0002-3479-0480
Dawid MaliszewskiDepartment of Organic Chemistry, Medical University of Białystok, Mickiewicza Street 2A, 15-222 Białystok, Poland.ORCID 0000-0002-8407-081X
Agnieszka WróbelDepartment of Organic Chemistry, Medical University of Białystok, Mickiewicza Street 2A, 15-222 Białystok, Poland.ORCID 0000-0003-4493-1547
Artur RatkiewiczDepartment of Physical Chemistry, Faculty of Chemistry, University of Białystok, Ciołkowskiego 1K Street, 15-245 Białystok, Poland.ORCID 0000-0003-1657-1871
Michał SienkiewiczDepartment of Physical Chemistry, Faculty of Chemistry, University of Białystok, Ciołkowskiego 1K Street, 15-245 Białystok, Poland.

Funding

Medical University of Bialystok SUB/2/DN/22/002/2204the Computational Center of the University of Bialystok Grant GO-008
6 · The paper itself

Abstract

The synthesis of eleven new and previously undescribed benzamides was designed. These compounds were specifically projected as potential inhibitors of the enzymes acetylcholinesterase (AChE) and β-secretase (BACE1). N,N'-(1,4-phenylene)bis(3-methoxybenzamide) was most active against AChE, with an inhibitory concentration of AChE IC

Indexed as

AcetylcholinesteraseAlzheimer DiseaseAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesCholinesterase InhibitorsHumansMolecular Docking SimulationStructure-Activity RelationshipAcetylcholinesteraseAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesBACE1 protein, humanCholinesterase InhibitorsAChE inhibitorsAlzheimer’s diseaseBACE1 inhibitorsbenzamidesdual inhibitors

Identifiers

PMID37834347
PMCPMC10573752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.